3-OH anthranilate analogues as novel therapeutics for Alzheimer's disease: NMR and MS to characterize binding interactions between Beta-Amyloid and analogues of high affinity
3-OH anthranilate analogues as novel therapeutics for Alzheimer's disease: NMR and MS to characterize binding interactions between Beta-Amyloid and analogues of high affinity